BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7741129)

  • 1. Decreased protein C inhibitor after percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction.
    Tanigawa M; Wada H; Minamikawa K; Wakita Y; Nagaya S; Mori T; Tamaki S; Nishikawa H; Kakuta Y; Nakano T
    Am J Hematol; 1995 May; 49(1):1-5. PubMed ID: 7741129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors.
    Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
    Soeki T; Tamura Y; Fukuda N; Ito S
    Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased tissue factor pathway inhibitor in patients with acute myocardial infarction.
    Kamikura Y; Wada H; Yamada A; Shimura M; Hiyoyama K; Shiku H; Tanigawa M; Nishikawa H; Yamada N; Isaka N; Nakano T; Kumeda K; Kato H
    Am J Hematol; 1997 Aug; 55(4):183-7. PubMed ID: 9257877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased activated protein C: protein C inhibitor complex and decreased protein C inhibitor levels in patients with chronic renal failure on maintenance hemodialysis.
    Takagi M; Wada H; Mukai K; Minamikawa K; Wakita Y; Deguchi K; Junji N; Hayashi T; Suzuki K; Shiku H
    Clin Appl Thromb Hemost; 1999 Apr; 5(2):113-6. PubMed ID: 10725991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of activated protein C-protein C inhibitor complex in patients with hypercoagulable states.
    Watanabe R; Wada H; Sakakura M; Mori Y; Nakasaki T; Okugawa Y; Gabazza EC; Hayashi T; Nishioka J; Suzuki K; Shiku H; Nobori T
    Am J Hematol; 2000 Sep; 65(1):35-40. PubMed ID: 10936861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma plasminogen activator inhibitor-1, tissue plasminogen activator and serum lipoprotein(a) after reperfusion therapy in acute myocardial infarction: comparison between sequential and direct percutaneous transluminal coronary angioplasty.
    Hara M; Ito K; Nawata T; Tsunematsu Y; Shimoyama N; Maeda T; Sato Y; Saikawa T; Sakata T
    Cardiology; 1995; 86(5):407-10. PubMed ID: 7585744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of plasma levels of activated protein C with recanalization of the infarct-related coronary artery after thrombolytic therapy in acute myocardial infarction.
    Takazoe K; Ogawa H; Yasue H; Sakamoto T; Oshima S; Arai H; Moriyama Y; Shimomura H; Hirai N; Kaikita K; Soejima H; Misumi K; Hosoda K
    Thromb Res; 1999 Jul; 95(1):37-47. PubMed ID: 10403685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemostatic abnormalities in patients with pulmonary embolism compared with that in deep vein thrombosis.
    Yamada N; Wada H; Nakase T; Minamikawa K; Nagaya S; Nakamura M; Hiraoka N; Fuzioka H; Hayashi T; Suzuki K
    Blood Coagul Fibrinolysis; 1995 Oct; 6(7):627-33. PubMed ID: 8562833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antithrombotic treatment (argatroban vs. heparin) in coronary angioplasty in angina pectoris: effects on inflammatory, hemostatic, and endothelium-derived parameters.
    Suzuki S; Matsuo T; Kobayashi H; Matsuo M; Shimamo C; Koide M; Sakamoto S
    Thromb Res; 2000 May; 98(4):269-79. PubMed ID: 10822073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
    Gyöngyösi M; Glogar D; Weidinger F; Domanovits H; Laggner A; Wojta J; Zorn G; Iordanova N; Huber K
    Am Heart J; 2004 Jan; 147(1):158-64. PubMed ID: 14691435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis.
    Ishiwata S; Tukada T; Nakanishi S; Nishiyama S; Seki A
    Am Heart J; 1997 Apr; 133(4):387-92. PubMed ID: 9124158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a) level does not predict restenosis after percutaneous transluminal coronary angioplasty.
    Alaigh P; Hoffman CJ; Korlipara G; Neuroth A; Dervan JP; Lawson WE; Hultin MB
    Arterioscler Thromb Vasc Biol; 1998 Aug; 18(8):1281-6. PubMed ID: 9714135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes of plasma hemostatic markers during percutaneous transluminal coronary angioplasty in patients with chronic coronary artery disease.
    Saito Y; Wada H; Yamamuro M; Inoue A; Shimura M; Hiyoyama K; Gabazza EC; Isaka N; Shiku H; Takeya H; Suzuki K; Kumeda K; Kato H; Nakano T
    Am J Hematol; 1999 Aug; 61(4):238-42. PubMed ID: 10440909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.
    Hirashima O; Ogawa H; Oshima S; Sakamoto T; Honda Y; Sakata S; Masuda T; Miyao Y; Yasue H
    Am Heart J; 1995 Nov; 130(5):933-9. PubMed ID: 7484753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method to measure plasma levels of activated protein C in complex with protein C inhibitor in patients with acute coronary syndromes.
    Strandberg K; Bhiladvala P; Holm J; Stenflo J
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):503-10. PubMed ID: 11685037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial.
    Inoue T; Yaguchi I; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
    Am Heart J; 2002 Oct; 144(4):E5. PubMed ID: 12360174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of a prothrombotic state in restenotic patients?
    Brack MJ; More RS; Pringle S; Gershlick AH
    Coron Artery Dis; 1994 Jun; 5(6):501-6. PubMed ID: 7952409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest.
    Figueras J; Monasterio Y; Lidón RM; Nieto E; Soler-Soler J
    J Am Coll Cardiol; 2000 Dec; 36(7):2036-43. PubMed ID: 11127437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.